Evidence map›Paper›PMID 41243720›Full record

ArticleClinical genetics2026

The Phenotypic and Genotypic Features of ADAMTSL4-Related Ocular Disease.

Katie M Williams, Wolfgang Berger, Samuel Koller, Fatma Kivrak Pfiffner, Alessandro Maspoli, Jiradet Gloggnitzer, Britta V T Brühwiler, Christina Stathopoulos, Francis Munier, Louise Allen and 5 more

Abstract readMulticenter Study
In one paragraph

Article in Clinical genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Katie M WilliamsDepartment of Ophthalmology, Sight and Sound Centre, Great Ormond Street Hospital, London, UK.
Wolfgang BergerInstitute of Medical Molecular Genetics, University of Zurich, Schlieren, Switzerland.
Samuel KollerInstitute of Medical Molecular Genetics, University of Zurich, Schlieren, Switzerland.
Fatma Kivrak PfiffnerInstitute of Medical Molecular Genetics, University of Zurich, Schlieren, Switzerland.
Alessandro MaspoliInstitute of Medical Molecular Genetics, University of Zurich, Schlieren, Switzerland.
Jiradet GloggnitzerInstitute of Medical Molecular Genetics, University of Zurich, Schlieren, Switzerland.
Britta V T BrühwilerDepartment of Ophthalmology, University Hospital and University of Zurich, Zurich, Switzerland.
Christina StathopoulosJules-Gonin Eye Hospital, Lausanne, Switzerland.
Francis MunierJules-Gonin Eye Hospital, Lausanne, Switzerland.
Louise AllenCambridge University Hospital NHS Trust, Cambridge, UK.
Christos IosifidisDivision of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Graeme C BlackDivision of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Panagiotis I SergouniotisDivision of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Ian Christopher LloydDepartment of Ophthalmology, Sight and Sound Centre, Great Ormond Street Hospital, London, UK.
Christina Gerth-KahlertDepartment of Ophthalmology, University Hospital and University of Zurich, Zurich, Switzerland.

Funding

NIHR Manchester Biomedical Research Centre NIHR203308Wellcome Trust 224643/Z/21/Z
6 · The paper itself

Abstract

Pathogenic variants in ADAMTSL4 are an important cause of isolated ectopia lentis with an increasing number of genetically confirmed cases internationally. We sought to better describe ocular features seen with pathogenic variants in ADAMTSL4. We performed a retrospective, multicenter study examining the phenotypic and genotypic spectrum of ADAMTSL4-associated ocular disease. We identified 41 individuals from 32 families with genetically confirmed ADAMTSL4-related disease across six tertiary referral centers across Europe. Identified participants had a young age of diagnosis (median 1.3 years) and a highly myopic refractive error (mean SE -10.27 D). A diagnosis of ectopia lentis et pupillae was made in a third of cases, with a younger age at diagnosis (median 0.5 years). Subluxation tended to be in the inferior direction (~33%). Zonules were noted to be missing or absent in the majority of cases. Sixteen different pathogenic variants in ADAMTSL4 were reported. A previously reported 20-bp deletion (c.767_786del) was highly prevalent in this cohort (23/32), and all ectopia lentis et pupillae cases carried this variant. ADAMTSL4-related disease tends to present at a younger age and be associated with higher myopia than other forms of ectopia lentis (such as FBN1). Early identification of typical phenotypic features alongside genetic testing can aid early, precise diagnosis and prevent unnecessary investigations.

Indexed as

ADAMTS ProteinsEctopia LentisEye DiseasesGenetic Predisposition to DiseaseAdolescentAdultChildChild, PreschoolFemaleGenetic Association StudiesGenotypeHumansInfantMaleMutationPhenotypeADAMTSL4 protein, humanADAMTS ProteinsADAMTSL4ectopia lentisectopia lentis et pupillaelens subluxationspherophakia

Identifiers

PMID41243720
PMCPMC12958011

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.